Common Equity: The sum of all common equity items.
MapLight Therapeutics, Inc. (MPLT) had Common Equity of $348.30M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-60.19M |
|
-- |
|
-- |
|
$63.55M |
|
$-63.55M |
|
$3.36M |
|
$-60.19M |
|
$-60.19M |
|
$-60.19M |
|
$-60.19M |
|
$-60.19M |
|
$-60.19M |
|
$-63.55M |
|
$-64.40M |
|
45.43M |
|
45.43M |
|
$-1.32 |
|
$-1.32 |
|
| Balance Sheet Financials | |
$318.79M |
|
$0.83M |
|
$49.56M |
|
$368.35M |
|
$19.29M |
|
-- |
|
$0.76M |
|
$20.05M |
|
|
Common Equity |
$348.30M |
$348.30M |
|
$348.30M |
|
45.44M |
|
| Cash Flow Statement Financials | |
$-96.05M |
|
$127.71M |
|
$-6.76M |
|
$46.94M |
|
$71.84M |
|
$24.90M |
|
$18.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.52 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-96.09M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-17.28% |
|
-17.28% |
|
-16.34% |
|
-17.28% |
|
$7.67 |
|
$-2.12 |
|
$-2.11 |
|